WHO ICTRP trial

To Compare effect of hyperbaric 0.75% ropivacaine and hyperbaric 0.5%…

CTRI/2022/10/046587 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2022/10/046587
Public title To Compare effect of hyperbaric 0.75% ropivacaine and hyperbaric 0.5% bupivacaine in terms of sensory and motor effect characteristics
Scientific title COMPARING BLOCK CHARACTERISTICS BETWEEN HYPERBARIC 0.75% ROPIVACAINE AND HYPERBARIC 0.5% BUPIVACAINE FOR SURGERIES UNDER SPINAL ANAESTHESIA
Primary sponsor Maulana Azad medical College and associated hospitals
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: O- Medical and Surgical
Interventions Intervention1: Hyperbaric ropivacaine in spinal anaesthesia: Giving 2.8ml of 0.75% hyperbaric ropivacaine for surgeries under spinal anaesthesia Control Intervention1: Hyperbaric bupivacaine in spinal anaesthesia: Giving 2.8ml of 0.5%…
Registration date Oct 18, 2022
Target size 124
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations